US-based pharmaceutical company Merck & Co. said on Friday that findings from a recent study showed its experimental antiviral pill molnupiravir reduced hospitalisations and deaths by half in people who had recently been infected with COVID-19. The company says it will soon ask health officials around the world to authorise its use.
Pharmaceutical company Merck says research found its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus. The study results were released by the company and have not been peer reviewed.
Merck said its experimental pill helped prevent serious illness and death in high-risk people infected with Covid-19, a step toward the virus’s first at-home treatment.
What people are saying?
cmdrMurlin99 Then do the right thing and give it away instead of turning it into a cash cow that we will end up not trusting because, gasp, we never know when you are telling the truth.
Karat Gold These pharma companies are rushing to collect on a gold mine (virus 19). Wise up people and don’t be fooled! Just because these companies say something doesn’t mean their products will do what the say it will.
Donna M Coles But we don’t know what’s in, it hasn’t been studied long enough. What other excuses do anti-vaxxers use that will all run out and put this drug in their system, but not a vaccine that has been studied for 3 decades.